Abstract
We have addressed two problems associated with the use of dihydropyridine calcium entry blockers in antihypertensive therapy, namely, potent vasodilation and short half-lives, by incorporating the representative blocker, darodipine, into a nanocapsular vehicle. In awake, renovascular hypertensive rats, darodipine nanocapsules lowered blood pressure when given orally or intramuscularly, and the initial fall in blood pressure was less marked than that observed with the same dose of darodipine dissolved in polyethylene glycol 400 (PEG). Intramuscular administration of the nanocapsular form of darodipine had an antihypertensive effect which lasted for at least 24 hr.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
B. Hubert, P. Maincent, M. Guerret, and J. Atkinson. Antihypertensive effect of a nanocapsular form of the calcium entry blocker, darodipine. Br. J. Pharmacol. 96:210P (1989).
F. R. Bühler. Age and pathophysiology-oriented antihypertensive response to calcium antagonists. J. Cardiovasc. Pharmacol. 12:S156–S162 (1988).
J. P. Chalmers, S. A. Smith, and L. M. H. Wing. Hypertension in the elderly: The role of calcium antagonists. J. Cardiovasc. Pharmacol. 12:S147–S155 (1988).
P. A. F. Jansen, F. W. Gribnau, B. P. Schulte, and E. F. Poels. Contribution of inappropriate treatment for hypertension to pathogenesis of stroke in the elderly. Br. Med. J. 1:914–917 (1986).
M. L. Tuck. Clinical care of the aging hypertensive patient. J. Cardiovasc. Pharmacol. 12:540–548 (1988).
P. Couvreur, L. Grislain, V. Lenearts, F. Brasseur, P. Guiot, and A. Bernacki. Biodegradable polymeric nanoparticles as drug carrier for antitumor agents. In P. Guiot and P. Couvreur (eds.), Polymeric Nanoparticles and Micro spheres, CRC Press, Boca Raton, FL, 1986, pp. 27–93.
C. Damge, C. Michel, M. Aprahamian, and P. Couvreur. New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carriers. Diabetes 37:246–251 (1988).
D. R. Abernethy and J. B. Schwartz. Pharmacokinetics of calcium antagonists under development. Clin. Pharmacokin. 15:1–14 (1988).
T. O. Morgan, J. Nawson, and R. Snowden. Compliance and the elderly hypertensive. Drugs 31:174–183 (1986).
N. Al Khouri-Fallouh, L. Roblot-Treupel, H. Fessi, J. P. Devissaguet, and F. Puisieux. Development of a new process for the manufacture of polyisobutylcyanoacrylate nanocapsules. Int. J. Pharm. 28:125–132 (1986).
R. P. Hof. Calcium antagonist and the peripheral circulation: Differences and similarities between PY 108-068, nicardipine, verapamil and diltiazem. Br. J. Pharmacol. 78:375–394 (1983).
A. Martin, J. Swarbrick, and A. Cammarata. Diffusion and dissolution. In A. Martin (ed.), Physical Pharmacy, Lea and Febiger, Philadelphia, 1983, pp. 399–444.
J. Atkinson, N. Boillat, A. Essadki, P. Lüthi, B. Maranda, and M. Sonnay. The role of the renin-angiotensin system in normotensive and hypertensive rats with varying renin status. Arch. Int. Pharmacodyn. Ther. 285:301–315 (1987).
J. Atkinson, H. P. Kaesermann, J. Lambelet, G. Peter, and L. Peter-Haetefi. The role of circulating renin in drinking in response to isoprenaline. J. Physiol. 291:61–73 (1979).
J. G. Wagner. Bioavailability. In J. G. Wagner (ed.), Fundamentals of Clinical Pharmacokinetics. Drug Intelligence Publications, Hamilton, 1975, pp. 337–358.
M. Aprahamian, C. Michel, W. Humbert, J. P. Devissaguet, and C. Damge. Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine. Biol. Cell. 61:69–76 (1987).
A. J. Spiegel and M. M. Noseworthy. Use of nonaqueous solvents in parenteral products. J. Pharm. Sci. 10:917–927 (1963).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hubert, B., Atkinson, J., Guerret, M. et al. The Preparation and Acute Antihypertensive Effects of a Nanocapsular Form of Darodipine, a Dihydropyridine Calcium Entry Blocker. Pharm Res 8, 734–738 (1991). https://doi.org/10.1023/A:1015897900363
Issue Date:
DOI: https://doi.org/10.1023/A:1015897900363